James Cullen - Agilent Technologies Independent Non-Executive Chairman of the Board

A -  USA Stock  

USD 152.31  2.01  1.34%

  Chairman
Mr. James G. Cullen is no longer NonExecutive Independent Director of Agilent Technologies, Inc., effective March 21, 2018. Mr. Cullen was President and Chief Operating Officer of Bell Atlantic Corporationrationration from 1997 to June 2000 and a member of the office of chairman from 1993 to June 2000. Prior to this appointment, Mr. Cullen was the President and Chief Executive Officer of the Telecom Group of Bell Atlantic from 1995 to 1997. Prior to the creation of Bell Atlantic on January 1, 1984, Mr. Cullen held management positions with New Jersey Bell from 1966 to 1981 and ATT from 1981 to 1983.
Age: 72  Chairman Since 2017      
408 345-8474  www.agilent.com

James Cullen Latest Insider Activity

Tracking and analyzing the buying and selling activities of James Cullen against Agilent Technologies stock is an integral part of due diligence when investing in Agilent Technologies. James Cullen insider activity provides valuable insight into whether Agilent Technologies is net buyers or sellers over its current business cycle. Note, Agilent Technologies insiders must abide by specific rules, including filing SEC forms every time they buy or sell Agilent Technologies'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Agilent Technologies Management Efficiency

Agilent Technologies has return on total asset of 7.82 % which means that for every 100 dollars spent on asset, it generated profit of $7.82. This is acceptable considering the industry classification. Similarly, it shows return on equity (ROE) of 19.31 %, implying that it made 19.31 on every $100 invested by shareholders. Agilent Technologies management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities. The current year Return on Investment is expected to grow to 10.71. The current year Return on Average Assets is expected to grow to 0.07. Agilent Technologies Current Assets are projected to decrease significantly based on the last few years of reporting. The past year's Current Assets were at 3.07 Billion. The current year Revenue to Assets is expected to grow to 0.68, whereas Total Assets are forecasted to decline to about 8.5 B.
The company has accumulated 3.12 B in total debt with debt to equity ratio (D/E) of 0.65, which looks OK as compared to the sector. Agilent Technologies has a current ratio of 1.96, which is considered satisfactory as compared to similar companies.
The market value of Agilent Technologies is measured differently than its book value, which is the value of Agilent that is recorded on the company's balance sheet. Investors also form their own opinion of Agilent Technologies' value that differs from its market value or its book value, called intrinsic value, which is Agilent Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilent Technologies' market value can be influenced by many factors that don't directly affect Agilent Technologies underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilent Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine Agilent Technologies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilent Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Similar Executives

Found 10 records

CHAIRMAN Since

Kevin ConroyExact Sciences Cor
2014
Yoav ShakedDario Health Corp
2018
Erez RaphaelDario Health Corp
2018
Willis LeeEmmaus Life Sciences
2019
Terrance GreggDexcom
2015
David KingLaboratory Corp
2019
Jonathan LordDexcom
2015
Ting ZhengGlobal Cord Blood
2018
Yuen KamGlobal Cord Blood
2012
Yutaka NiiharaEmmaus Life Sciences
2019
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company was incorporated in 1999 and is headquartered in Santa Clara, California. Agilent Technologies operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 16500 people. Agilent Technologies (A) is traded on New York Stock Exchange in USA. It is located in 5301 Stevens Creek Blvd., Santa Clara, CA 95051, United States and employs 16,500 people. Agilent Technologies is listed under Measuring and Control category by Fama And French industry classification.

Agilent Technologies Leadership Team

Elected by the shareholders, the Agilent Technologies' board of directors comprises two types of representatives: Agilent Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Agilent. The board's role is to monitor Agilent Technologies' management team and ensure that shareholders' interests are well served. Agilent Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Agilent Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Padraig McDonnell, Senior Vice President and Presidentident - Agilent CrossLab Group
Daniel Podolsky, Independent Director
Hans Bishop, Independent Director
George Scangos, Independent Director
Sue Rataj, Independent Director
Jacob Thaysen, Senior Vice President, President - Life Sciences and Applied Markets Group
Samraat Raha, Senior Vice President, President - Diagnostics and Genomics Group
Mark Doak, Senior Vice President, President - Agilent CrossLab Group
Paul Clark, Independent Director
Mala Anand, Independent Director
Robert McMahon, Chief Financial Officer, Senior Vice President
Ankur Dhingra, Investor Relations
Allison Ballmer, Vice President - Strategy and Corporate Development
Hajime Tada, Interim General Counsel
James Cullen, Independent Non-Executive Chairman of the Board
Michael McMullen, CEO and President Director and Member of Executive Committee
Patrick Kaltenbach, Sr. VP and President of Life Sciences and Applied Markets Group (LSAG) Bus. Unit
Rodney Gonsalves, Chief Accounting Officer, Vice President, Corporate Controllership
Henrik AncherJensen, Senior Vice President, Agilent and President - Order Fulfillment
Dow Wilson, Independent Director
Heidi Kunz, Independent Director
Dominique Grau, Senior Vice President of Human Resources and Global Communications
Susan Rataj, Independent Director
Heidi Fields, Independent Director
Michael Tang, Senior Vice President General Counsel, Secretary
Alicia Rodriguez, Vice President - Investor Relations
Tadataka Yamada, Independent Director
Didier Hirsch, CFO and Sr. VP
Katharine Knobil, Chief Medical Officer.
Boon Koh, Non-Executive Independent Chairman of the Board
Robert Herbold, Independent Director

Agilent Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Agilent Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Agilent Technologies without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Idea Optimizer Now

   

Idea Optimizer

Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
All  Next Launch Module

Pair Trading with Agilent Technologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Agilent Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agilent Technologies will appreciate offsetting losses from the drop in the long position's value.

Agilent Technologies Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Agilent Technologies and Global Cord Blood. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Please continue to Trending Equities. Note that the Agilent Technologies information on this page should be used as a complementary analysis to other Agilent Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Agilent Stock analysis

When running Agilent Technologies price analysis, check to measure Agilent Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Agilent Technologies is operating at the current time. Most of Agilent Technologies' value examination focuses on studying past and present price action to predict the probability of Agilent Technologies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Agilent Technologies' price. Additionally, you may evaluate how the addition of Agilent Technologies to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
CEO Directory
Screen CEOs from public companies around the world
Go
The market value of Agilent Technologies is measured differently than its book value, which is the value of Agilent that is recorded on the company's balance sheet. Investors also form their own opinion of Agilent Technologies' value that differs from its market value or its book value, called intrinsic value, which is Agilent Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilent Technologies' market value can be influenced by many factors that don't directly affect Agilent Technologies underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilent Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine Agilent Technologies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilent Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.